# Early Versus Late BCG Vaccination in HIV-1 Exposed Infants in Uganda in Uganda

> **NCT02606526** · PHASE3 · COMPLETED · sponsor: **Makerere University** · enrollment: 4500 (actual)

## Conditions studied

- Severe Illness
- Septicaemia
- Diarrhoea
- Lower Respiratory Infection

## Interventions

- **BIOLOGICAL:** BCG at birth
- **BIOLOGICAL:** Control arm: Delayed BCG

## Key facts

- **NCT ID:** NCT02606526
- **Lead sponsor:** Makerere University
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-07
- **Primary completion:** 2024-06-21
- **Final completion:** 2024-06-21
- **Target enrollment:** 4500 (ACTUAL)
- **Last updated:** 2025-03-04

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02606526

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02606526, "Early Versus Late BCG Vaccination in HIV-1 Exposed Infants in Uganda in Uganda". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT02606526. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*